Department of Electrical and Computer Engineering, University of Calgary, Calgary, AB, Canada.
Neurogastroenterol Motil. 2011 Mar;23(3):271-8, e122. doi: 10.1111/j.1365-2982.2010.01636.x. Epub 2010 Dec 5.
Gastric electrical stimulation (GES) is an avenue for treating gastroparesis and obesity by controlling gastric motility using electrically mediated gastric contractions. Neural gastrointestinal electrical stimulation (NGES) is a GES modality capable of producing strong lumen-occluding local gastric contractions. Conversely, Enterra ™ Therapy, a commercial implantable gastric electrical stimulator, has been utilized to treat symptoms of gastroparesis, but its nominal electrical parameters are not capable of generating lumen-occluding contractions. However, comparative studies between these two stimulation modalities are lacking.
Strain gauge transducers complemented by endoscopic monitoring have been utilized to register gastric contractions invoked with NGES and Enterra neurostimulators in four acute dogs. Mucosal and serosal electrode implantations, 'nominal' and 'maximum' electrical parameters, and longitudinal and transverse electrode placements have been tested with each neurostimulator type.
Strong lumen-occluding, circumferential contractions were induced with a wide variety of NGES parameters utilizing both transverse and longitudinal electrode configurations from the serosal side of the stomach. Similarly, local gastric contractions were observed with the Enterra neurostimulator programmed at its 'maximum' electrical parameters but only when utilizing transverse serosal electrode implantation. Under 'maximum' electrical parameters Enterra was not capable of producing registerable gastric contractions with longitudinally implanted serosal electrodes. Mucosal electrode implantations did not result in GES-invoked gastric contractions in both stimulation modalities.
CONCLUSIONS & INFERENCES: Enterra Therapy is capable of producing gastric contractions under 'maximum' parameters and transverse electrode configuration. Neural gastrointestinal electrical stimulation produces stronger, lumen-occluding contractions under a wider range of electrode configurations and parameters.
胃电刺激(GES)是一种通过电介导的胃收缩来控制胃动力以治疗胃轻瘫和肥胖的方法。神经胃肠电刺激(NGES)是一种 GES 方式,能够产生强烈的管腔闭塞性局部胃收缩。相反,Enterra ™ Therapy 是一种商业可植入胃电刺激器,已用于治疗胃轻瘫症状,但它的标称电参数无法产生管腔闭塞性收缩。然而,这两种刺激方式之间缺乏比较研究。
应变计换能器辅以内镜监测已用于在四只急性犬中记录 NGES 和 Enterra 神经刺激器引起的胃收缩。已经测试了粘膜和浆膜电极植入、“标称”和“最大”电参数以及纵向和横向电极放置,每种神经刺激器类型都进行了测试。
利用从胃浆膜侧的各种横向和纵向电极配置,可通过 NGES 参数产生强烈的管腔闭塞性、环形收缩。同样,当以 Enterra 神经刺激器的“最大”电参数编程时,也观察到局部胃收缩,但仅当使用横向浆膜电极植入时。在“最大”电参数下,Enterra 无法在具有纵向植入的浆膜电极下产生可记录的胃收缩。在这两种刺激方式中,粘膜电极植入均未导致胃电刺激引起的胃收缩。
Enterra 疗法能够在“最大”参数和横向电极配置下产生胃收缩。神经胃肠电刺激在更广泛的电极配置和参数下产生更强、管腔闭塞的收缩。